GLP-1 receptor agonist weight loss drugs suppress appetite for food but may also reduce mood and desire for sex in some ...

Federal investigators say that a Chinese drug manufacturer, previously on the Food and Drug Administration’s list of preapproved foreign companies allowed to import GLP-1 ingredients, was able to ...

Medicare previously covered GLP-1s only if the beneficiary also had a condition such as diabetes, sleep apnea, high blood ...

In contrast, one research trial using GLP-1 drugs on obese research subjects did not show a benefit from GLP-1 in the ...

The percentage of American adults who are currently taking a GLP-1 drug for weight loss is 11%, according to a new survey ...

About one in nine Americans take a GLP-1 medication for weight loss, results from a new Gallup poll released on Tuesday found ...

Eli Lilly makes the best-selling GLP-1 drug, and sales are accelerating.

Quality-of-life effects still a major unknown, researchers say ...

GLP-1 drugs are now a fixture of American health culture: 1 in 8 U.S. adults is taking a medication like Ozempic or Wegovy, ...

Ozempic and other GLP-1s could have a surprising effect on the progression of cancer.

A target trial emulation found that people with type 2 diabetes who started glucagon-like peptide-1 receptor agonist (GLP-1RA ...

The “fauxzempic” era is well underway. Many brands are marketing alternatives to GLP-1 weight-loss drugs, but certain foods ...